Phreesia, Inc. (NYSE:PHR) Receives Consensus Rating of “Buy” from Brokerages

Shares of Phreesia, Inc. (NYSE:PHR) have been assigned a consensus recommendation of “Buy” from the twelve brokerages that are covering the company, Marketbeat reports. Twelve equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $31.00.

Several analysts have recently commented on PHR shares. JMP Securities restated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. Citigroup raised their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and boosted their target price for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Robert W. Baird reduced their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 price objective on shares of Phreesia in a report on Friday, January 10th.

Insider Buying and Selling at Phreesia

In other news, CFO Balaji Gandhi sold 3,195 shares of the business’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $85,018.95. Following the completion of the transaction, the chief financial officer now directly owns 148,509 shares of the company’s stock, valued at $3,951,824.49. The trade was a 2.11 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Evan Roberts sold 1,785 shares of the company’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $26.98, for a total value of $48,159.30. Following the completion of the sale, the chief operating officer now owns 768,208 shares in the company, valued at $20,726,251.84. This represents a 0.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 100,034 shares of company stock valued at $2,378,581. Insiders own 5.80% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Deerfield Management Company L.P. Series C purchased a new stake in shares of Phreesia during the second quarter worth about $4,078,000. Champlain Investment Partners LLC boosted its position in Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after acquiring an additional 97,847 shares during the last quarter. Sei Investments Co. boosted its position in Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after acquiring an additional 95,058 shares during the last quarter. Squarepoint Ops LLC raised its holdings in Phreesia by 56.3% in the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after acquiring an additional 90,215 shares during the last quarter. Finally, State Street Corp lifted its stake in shares of Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares during the period. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Stock Up 1.6 %

Phreesia stock opened at $27.24 on Thursday. The stock has a 50 day moving average of $23.54 and a two-hundred day moving average of $22.84. Phreesia has a twelve month low of $17.07 and a twelve month high of $29.16. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of -18.53 and a beta of 0.94. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter in the prior year, the business earned ($0.58) earnings per share. The company’s quarterly revenue was up 16.6% compared to the same quarter last year. As a group, research analysts expect that Phreesia will post -1.1 earnings per share for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.